Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 150 for Ovarian

Edit search filters
  1. Changes in Blood Components in Patients with Ovarian Cancer

    Rochester, MN

  2. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors

    Rochester, MN

  3. Saliva and remote monitoring of active Cytomegalovirus infection and symptoms during ovarian cancer treatment

    Rochester, MN

  4. Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study to Learn About How Women Metabolize and Respond to Opioids When Used for Managing Post-operative Pain

    Rochester, MN

  6. The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

    Albert Lea, MN, Mankato, MN

  7. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC

    Rochester, MN

  8. ADVANCE 2: ADdressing Views of African AmericaNs on CancEr Screening

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  9. ADVANCE

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  10. Use of Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy and Risk of Malignancy in Genetic Mutation Carriers

    Rochester, MN

.

Mayo Clinic Footer